WallStSmart

High Tide Inc (HITI)vsScienture Holdings, Inc. (SCNX)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

High Tide Inc generates 96298% more annual revenue ($629.85M vs $653,390). SCNX leads profitability with a 0.0% profit margin vs -7.4%. SCNX earns a higher WallStSmart Score of 33/100 (F).

HITI

Avoid

30

out of 100

Grade: F

Growth: 6.0Profit: 3.5Value: 5.0Quality: 4.5
Piotroski: 1/9Altman Z: 0.68

SCNX

Avoid

33

out of 100

Grade: F

Growth: 4.0Profit: 2.5Value: 8.3Quality: 5.0
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HITI.

SCNXUndervalued (+91.2%)

Margin of Safety

+91.2%

Fair Value

$5.10

Current Price

$0.46

$4.64 discount

UndervaluedFair: $5.10Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HITI1 strengths · Avg: 8.0/10
Revenue GrowthGrowth
25.2%8/10

Revenue surging 25.2% year-over-year

SCNX2 strengths · Avg: 10.0/10
P/E RatioValuation
0.7x10/10

Attractively priced relative to earnings

Price/BookValuation
0.1x10/10

Reasonable price relative to book value

Areas to Watch

HITI4 concerns · Avg: 3.0/10
Market CapQuality
$196.76M3/10

Smaller company, higher risk/reward

Operating MarginProfitability
2.3%3/10

Operating margin of 2.3%

Debt/EquityHealth
1.713/10

Elevated debt levels

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

SCNX4 concerns · Avg: 3.0/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$19.69M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Return on EquityProfitability
-24.1%2/10

ROE of -24.1% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HITI

The strongest argument for HITI centers on Revenue Growth. Revenue growth of 25.2% demonstrates continued momentum.

Bull Case : SCNX

The strongest argument for SCNX centers on P/E Ratio, Price/Book.

Bear Case : HITI

The primary concerns for HITI are Market Cap, Operating Margin, Debt/Equity. Debt-to-equity of 1.71 is elevated, increasing financial risk.

Bear Case : SCNX

The primary concerns for SCNX are EPS Growth, Market Cap, Profit Margin.

Key Dynamics to Monitor

HITI profiles as a growth stock while SCNX is a value play — different risk/reward profiles.

HITI is growing revenue faster at 25.2% — sustainability is the question.

HITI generates stronger free cash flow (4M), providing more financial flexibility.

Monitor PHARMACEUTICAL RETAILERS industry trends, competitive dynamics, and regulatory changes.

Bottom Line

SCNX scores higher overall (33/100 vs 30/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

High Tide Inc

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

High Tide Inc. is a vertically integrated company in the cannabis market in Canada, the United States and internationally. The company is headquartered in Calgary, Canada.

Visit Website →

Scienture Holdings, Inc.

HEALTHCARE · PHARMACEUTICAL RETAILERS · USA

Scienture Holdings, Inc. (SCNX) is an innovative biotechnology company focused on developing cutting-edge therapeutic solutions for neurological disorders. With a robust drug development pipeline supported by advanced technology and a highly skilled research team, Scienture is committed to meeting unmet medical needs and improving patient outcomes. The company's strategic emphasis on scientific excellence, regulatory compliance, and collaborative partnerships positions it well for growth within the burgeoning healthcare sector, highlighting its potential to make significant contributions to global health advancements.

Want to dig deeper into these stocks?